OptimizeRx Corp
May 22, 2014
THE UNITED STATES SECURITIES
AND EXCHANGE COMMISSION
Attn: Mark P. Shuman
Division of Corporation Finance
Mail Stop 7010
100 F. Street NE
Washington, D.C. 20549-7010
Re: | OptimizeRx Corp
Registration Statement on Form S-1 File No. 333-195210 |
Dear Mr. Shuman:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, OptimizeRx Corp (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 to 4:00 PM Eastern Standard Time on May 28, 2014, or as soon thereafter as is practicable.
The Company acknowledges the following:
Thank you for your assistance. Please call with any questions.
OptimizeRx Corp
By:
/s/ David Harrell
David Harrell
Chief Executive Officer
400 Water Street Suite 200
Rochester, MI, 48307- Phone: 248 651-6568